X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Dr. Reddys with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs JUBILANT LIFE SCIENCES - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB JUBILANT LIFE SCIENCES DR. REDDYS LAB/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 19.8 12.8 154.6% View Chart
P/BV x 3.0 1.8 168.3% View Chart
Dividend Yield % 0.8 0.7 120.1%  

Financials

 DR. REDDYS LAB   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
JUBILANT LIFE SCIENCES
Mar-18
DR. REDDYS LAB/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs2,8751,039 276.7%   
Low Rs1,888600 314.7%   
Sales per share (Unadj.) Rs930.2482.6 192.8%  
Earnings per share (Unadj.) Rs117.440.7 288.3%  
Cash flow per share (Unadj.) Rs185.867.4 275.7%  
Dividends per share (Unadj.) Rs20.003.00 666.7%  
Dividend yield (eoy) %0.80.4 229.4%  
Book value per share (Unadj.) Rs844.4262.3 321.9%  
Shares outstanding (eoy) m166.07155.79 106.6%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x2.61.7 150.8%   
Avg P/E ratio x20.320.1 100.8%  
P/CF ratio (eoy) x12.812.2 105.4%  
Price / Book Value ratio x2.83.1 90.3%  
Dividend payout %17.07.4 231.2%   
Avg Mkt Cap Rs m395,496127,670 309.8%   
No. of employees `00022.02.4 901.7%   
Total wages/salary Rs m33,56215,559 215.7%   
Avg. sales/employee Rs Th7,032.830,861.4 22.8%   
Avg. wages/employee Rs Th1,527.96,387.0 23.9%   
Avg. net profit/employee Rs Th887.72,604.4 34.1%   
INCOME DATA
Net Sales Rs m154,48275,178 205.5%  
Other income Rs m3,375400 843.1%   
Total revenues Rs m157,85775,579 208.9%   
Gross profit Rs m31,78215,184 209.3%  
Depreciation Rs m11,3484,151 273.4%   
Interest Rs m8892,843 31.3%   
Profit before tax Rs m22,9208,591 266.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,8582,247 171.7%   
Profit after tax Rs m19,5006,344 307.4%  
Gross profit margin %20.620.2 101.9%  
Effective tax rate %16.826.2 64.4%   
Net profit margin %12.68.4 149.6%  
BALANCE SHEET DATA
Current assets Rs m111,10131,898 348.3%   
Current liabilities Rs m58,97320,047 294.2%   
Net working cap to sales %33.715.8 214.1%  
Current ratio x1.91.6 118.4%  
Inventory Days Days7968 117.4%  
Debtors Days Days9455 171.6%  
Net fixed assets Rs m101,24560,715 166.8%   
Share capital Rs m830156 532.7%   
"Free" reserves Rs m139,40640,710 342.4%   
Net worth Rs m140,23640,865 343.2%   
Long term debt Rs m22,00030,478 72.2%   
Total assets Rs m224,65696,176 233.6%  
Interest coverage x26.84.0 665.9%   
Debt to equity ratio x0.20.7 21.0%  
Sales to assets ratio x0.70.8 88.0%   
Return on assets %9.19.6 95.0%  
Return on equity %13.915.5 89.6%  
Return on capital %14.916.0 93.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m88,67314,402 615.7%   
Fx outflow Rs m19,10412,044 158.6%   
Net fx Rs m69,5692,358 2,950.3%   
CASH FLOW
From Operations Rs m28,70413,032 220.3%  
From Investments Rs m-7,727-6,177 125.1%  
From Financial Activity Rs m-21,326-9,011 236.7%  
Net Cashflow Rs m-314-2,123 14.8%  

Share Holding

Indian Promoters % 25.5 45.6 55.9%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 5.4 8.7 62.1%  
FIIs % 35.3 21.2 166.5%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 21.1 72.5%  
Shareholders   75,885 23,815 318.6%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   WOCKHARDT  J.B.CHEMICALS  ORCHID PHARMA LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Erase Gains; Sensex Ends 52 Points Higher(Closing)

After opening the day higher, Indian share markets witnessed negative trading activity during closing hours and ended their trading session marginally higher.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

My Top 3 Dividend Millionaire Stocks(Profit Hunter)

Aug 7, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Aug 19, 2019 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS